retratrutide dose
-
Retatrutide (GLP-3): Dosing, Results & Side Effects Guide
Curated By Nelson Vergel | ExcelMale.com | Updated March 2026 Key Takeaways Retatrutide is a first-in-class triple hormone receptor agonist (GLP-1 + GIP + glucagon) from Eli Lilly, currently in Phase 3 clinical trials under the TRIUMPH program. In Phase 3 (TRIUMPH-4), participants on the...- Nelson Vergel
- Thread
- retatrutide retatrutide versus mounjaro wegovy retratrutide dose retratrutide weight loss retrospective study
- Replies: 1
- Forum: Weight Loss Options
Sponsors
retratrutide dose
